Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease.

Sungmin KimJung Nam AnYoung Rim SongSung Gyun KimHyung Seok LeeAJin ChoJwa-Kyung Kim

Published in: PloS one (2022)

The use of dulaglutide provided adequate glycemic control irrespective of CKD stage and was associated with a reduced decline in the eGFR in the CKD population.

Keyphrases

glycemic control
chronic kidney disease
type diabetes
blood glucose
small cell lung cancer
epidermal growth factor receptor
weight loss
tyrosine kinase